• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Aortic Valve Replacement for Severe Aortic Stenosis in the Elderly

  • Fri, 9/5/08 - 4:54pm
  • 0 Comments
  • 1617 reads

To the Editor:
Dr. Aronow’s1 recommendation for aortic valve replacement was both informative and directional for patients of elderly age with severe aortic stenosis. I have three very symptomatic patients in their nineties with severe aortic stenosis, with nearly identical clinical presentations as the 80-year-old woman portrayed by Dr. Aronow in his Q&A; all are being treated for congestive heart failure (CHF) with diuretics, angiotensin-converting enzyme (ACE) inhibitor therapy, and beta-blocker therapy. What to do? These patients have no other medical conditions that would contradict aggressive intervention.

Dr. Frank M. Shanley, PA, FACC, FCCP
Diplomate, Internal Medicine and Cardiology
Denville, NJ

Reference
1. Aronow WS. Q & A with the Expert on: Valvular aortic stenosis. Annals of Long-Term Care: Clinical Care and Aging 2007;15(6):29-30.

Response from the author:

Roberts et al1 reported on nine nonagenarians who had aortic valve replacement (AVR) for severe aortic stenosis at Baylor University Medical Center from 2000 to 2006. The left ventricular ejection fraction was less than 50% in three of the nine patients (33%) (25%, 30%, and 15%). Eight of the nine patients (89%) had concomitant coronary artery bypass grafting at the time of AVR. Of the nine patients, one (11%) died postoperatively, two others (22%) died at 874 days and at 1011 days after AVR, and six (67%) are alive at 738 days, 874 days, 899 days, 1231 days, 1413 days, and 2230 days after AVR.

I know of one nonagenarian who is asymptomatic and working 4 years after AVR for severe aortic stenosis and congestive heart failure. This man also had mitral valve repair and coronary artery bypass grafting at the time of AVR.

These data should be discussed thoroughly with the patients and their families in order that a well-informed decision be made regarding AVR. Of course, an experienced cardiovascular surgeon with excellent results in AVR must perform the AVR if the patient wishes to have this done.

Wilbert S. Aronow, MD, AGSF
Westchester Medical Center/New York Medical College
Valhalla, NY

Reference
1. Roberts WC, Ko JM, Matter GJ. Aortic valve replacement for aortic stenosis in nonagenarians. Am J Cardiol 2006;98:1251-1253.

image description image description


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

How to Create Collegiality in a Difference of Opinion: Part 2

Neil Baum MD
2/6/12 | 0 Comments | 14 reads

How to Create Collegiality in a Difference of Opinion: Part 1

Neil Baum MD
2/3/12 | 0 Comments | 41 reads

Dutasteride vs Low Grade Prostate Cancer

Alvin B Lin MD FAAFP
1/31/12 | 0 Comments | 64 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications